1-3 of 3
Deborah Chirnomas, MD, MPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Palatability and Tolerability of Deferasirox (Exjade®) Taken with Meals, Different Liquids, or Crushed and Added to Food

Stuart L Goldberg, MD, Patricia Giardina, MD, Joan Parkhurst Cain, MD, Deborah Chirnomas, MD, MPH, Jason Esposito, Carole S. Paley, MD, Elliott Vichinsky, MD
Journal: Blood
Blood (2010) 116 (21): 5155.
https://doi.org/10.1182/blood.V116.21.5155.5155
Published: 2010
Journal Articles

Strategies to Improve Iron Chelation In Thalassemia Patients Poorly Responsive to Deferasirox:

Deborah Chirnomas, MD, MPH, Aleksandra Yakhkind, MS, Carole S. Paley, MD, Ellis J. Neufeld, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4279.
https://doi.org/10.1182/blood.V116.21.4279.4279
Published: 2010
Journal Articles

A Phase 1B Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FBS0701, a Novel Oral Iron Chelator for the Treatment of Chronic Iron Overload

Hugh Y. Rienhoff, Jr, MD, ip Viprakasit, MD, D, Phil, Lay H. Tay, MBBS, FRCPA, Paul Harmatz, MD, Elliott Vichinsky, MD, Deborah Chirnomas, MD, MPH, Janet Kwiatkowski, MD, Amy E Tapper, PhD, John B Porter, MD, Ellis J. Neufeld, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2057.
https://doi.org/10.1182/blood.V116.21.2057.2057
Published: 2010